TWAPF Dividend: Towa Pharmaceutical Co Ltd Yield Insights
Home
Stock
TWAPF
Towa Pharmaceutical Co Ltd (TWAPF) Price
TWAPF Stock Price Chart
TWAPF Financial
Towa Pharmaceutical Co Ltd
$0
0%
$0
$0
0%
$0
Overview
Forecast
Earning
Dividends
Financials
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Market Sentiment
Technical Analysis
Crypto Comparison
Home Page
Trading Strategies
Megabrain Investors Picks
Trading Mindshare
Technical Signals
Pivot Alert
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
Stocks Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2025 Edgen Powered by
Ask AI About TWAPF
Income
Balance sheet
Cash flow
Annual
Quarterly
TWAPF Income
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
262,177
259,594
227,934
208,859
165,615
154,900
Revenue Growth (YoY)
11%
14%
9%
26%
7%
40%
Cost of Revenue
167,116
164,865
146,551
136,145
95,429
89,448
Gross Profit
95,061
94,729
81,383
72,714
70,186
65,452
Selling, General & Admin
72,284
55,274
50,493
51,934
39,492
34,885
Research & Development
--
16,212
13,242
15,265
11,488
10,642
Operating Expenses
72,285
71,487
63,736
67,200
50,981
45,529
Other Non Operating Income (Expenses)
1,181
1,053
528
906
59
533
Pretax Income
21,706
26,330
24,459
4,605
22,246
18,728
Income Tax Expense
5,701
7,343
8,286
2,404
6,331
4,770
Net Income
16,004
18,986
16,173
2,201
15,914
13,958
Net Income Growth
-5%
17%
635%
-86%
14%
-4%
Shares Outstanding (Diluted)
49.22
49.22
49.22
49.22
50.32
51.27
Shares Change (YoY)
0%
0%
0%
-2%
-2%
-4%
EPS (Diluted)
325.1
385.69
328.58
44.71
316.22
272.2
EPS Growth
-5%
17%
635%
-86%
16%
0%
Free Cash Flow
976
-7,610
-31,112
-27,924
8,553
2,475
Free Cash Flow Per Share
19.82
-154.59
-632.09
-567.3
169.95
48.26
Gross Margin
36.25%
36.49%
35.7%
34.81%
42.37%
42.25%
Operating Margin
8.68%
8.95%
7.74%
2.64%
11.59%
12.86%
Profit Margin
6.1%
7.31%
7.09%
1.05%
9.6%
9.01%
Free Cash Flow Margin
0.37%
-2.93%
-13.64%
-13.36%
5.16%
1.59%
EBITDA
43,389
43,341
35,535
24,923
30,159
30,348
EBITDA Margin
16.54%
16.69%
15.59%
11.93%
18.21%
19.59%
D&A For EBITDA
20,613
20,099
17,888
19,409
10,954
10,425
EBIT
22,776
23,242
17,647
5,514
19,205
19,923
EBIT Margin
8.68%
8.95%
7.74%
2.64%
11.59%
12.86%
Effective Tax Rate
26.26%
27.88%
33.87%
52.2%
28.45%
25.46%
Follow-Up Questions
Towa Pharmaceutical Co Ltd 的關鍵財務報表是什麼?
TWAPF 的關鍵財務比率是什麼?
Towa Pharmaceutical Co Ltd 的收入按細分市場或地理位置如何劃分?
Towa Pharmaceutical Co Ltd 是否盈利?
Towa Pharmaceutical Co Ltd 有負債嗎?
Towa Pharmaceutical Co Ltd 的流通股有多少?